Literature DB >> 6539041

Ophthalmological findings in nephropathia epidemica in Lapland.

K M Saari, S Luoto.   

Abstract

We report ophthalmological findings in 15 cases of nephropathia epidemica. The patients, 13 men and 2 women, were 20 to 62 (mean 30) years of age. The onset of the disease was characterized by high fever, nausea, headache, abdominal pain, backache, somnolence, red throat, proteinuria, and oliguria. The symptoms subsided rapidly during the polyuria stage. Transitory myopia occurred in 8 patients (53%). Conjunctival injection and haemorrhages were seen in 3 patients (20%). One patient had acute glaucoma with oedema in the cornea and shallowing of the anterior chamber, with subsequent anterior uveitis and haemorrhages in the ocular fundus, and another patients had acute glaucoma. Three patients had photophobia which occurred in 2 patients without any glaucoma or anterior uveitis.

Entities:  

Mesh:

Year:  1984        PMID: 6539041     DOI: 10.1111/j.1755-3768.1984.tb08400.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  4 in total

1.  [Bilateral acute angle-closure glaucoma due to an infection with Hantavirus].

Authors:  A Zimmermann; B Lorenz; W Schmidt
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

2.  Myopic shift and its mechanism in nephropathia epidemica or Puumala virus infection.

Authors:  M Kontkanen; T Puustjärvi; J Lähdevirta
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

3.  Changes in the Ocular Parameters of Patients with Graves' Disease after Antithyroid Drug Treatment.

Authors:  Je-Sang Lee; Dong-Ju Yeom; Seung-Kwan Nah; Bo-Yeon Kim; Sun-Young Jang
Journal:  Medicina (Kaunas)       Date:  2021-04-25       Impact factor: 2.430

Review 4.  Central Nervous System and Ocular Manifestations in Puumala Hantavirus Infection.

Authors:  Nina Hautala; Terhi Partanen; Anna-Maria Kubin; Heikki Kauma; Timo Hautala
Journal:  Viruses       Date:  2021-05-31       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.